In documents tabled in the House of Commons on Jan. 30, Health Canada responded to COVID-19 vaccination questions submitted by Conservative MP Collin Carrie on issues such as adverse events, the “gene therapy” nature of the mRNA shots, and lingering spike protein.
Carrie asked a broad range of technical questions, such as whether the Pfizer clinical trials had tested for “biomarkers (e.g. troponin-1 as an indicator for heart damage, C-reactive protein for inflammation) associated with possible vaccine adverse effects related to spike protein in the blood circulation.”
These tests can help determine if an individual is suffering from heart inflammation, such as myocarditis….